Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mBio
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article

Mycobacterium tuberculosis PhoY Proteins Promote Persister Formation by Mediating Pst/SenX3-RegX3 Phosphate Sensing

Sarah B. Namugenyi, Alisha M. Aagesen, Sarah R. Elliott, Anna D. Tischler
Christina L. Stallings, Editor
Sarah B. Namugenyi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alisha M. Aagesen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah R. Elliott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna D. Tischler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna D. Tischler
Christina L. Stallings
Washington University in St. Louis School of Medicine
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mBio.00494-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplemental Material
  • FIG 1 
    • Open in new tab
    • Download powerpoint
    FIG 1 

    RegX3-regulated genes are overexpressed in the ΔphoY1 ΔphoY2 mutant. RNA was isolated from M. tuberculosis WT, and the indicated deletion mutants grown to mid-exponential phase (OD600 0.5) in 7H9 medium. Expression of select transcripts was measured using quantitative reverse transcription-PCR, and the results normalized to the sigA transcript level. Data shown are the mean values ± standard deviations of three independent experiments. #, no detectable transcript. Asterisks indicate statistically significant transcript levels compared to the results for the WT, as follows: *, P < 0.05; **, P < 0.005; ***, P < 0.0005. (A) phoY1, phoY2, udgA, mgtA, and rv0784 transcripts were measured in M. tuberculosis WT and ΔphoY1, ΔphoY2, ΔphoY1 ΔphoY2, ΔphoY1 ΔphoY2/pMVphoY1, and ΔphoY1 ΔphoY2/pMVphoY2 mutants. (B) regX3, udgA, mgtA, and rv0784 transcripts were quantified in M. tuberculosis WT and ΔphoY1 ΔphoY2, ΔphoY1 ΔphoY2 ΔregX3, and ΔphoY1 ΔphoY2 ΔregX3/pNDregX3 mutants.

  • FIG 2 
    • Open in new tab
    • Download powerpoint
    FIG 2 

    Deletion of phoY1 and phoY2 causes a stationary-phase growth defect. M. tuberculosis WT and ΔphoY1, ΔphoY2, ΔphoY1 ΔphoY2, ΔphoY1 ΔphoY2/pMVphoY1, and ΔphoY1 ΔphoY2/pMVphoY2 mutants were grown to mid-exponential phase (OD600 of 0.5) in 7H9 medium, diluted to an OD600 of 0.05 in fresh 7H9 medium, and incubated at 37°C with shaking. (A and C) Optical density (OD600) was measured daily. (B and D) Viable CFU were enumerated by plating serially diluted cultures on 7H10 agar. For all panels, results shown are the average values ± standard deviations of three independent experiments.

  • FIG 3 
    • Open in new tab
    • Download powerpoint
    FIG 3 

    Deletion of phoY1 and phoY2 decreases persister frequency in M. tuberculosis. The indicated M. tuberculosis strains were grown in 7H9 medium to mid-exponential phase (OD600 0.5) and diluted to an OD600 of 0.2 before adding antibiotics. Cultures were incubated at 37°C with aeration, and viable CFU/ml were enumerated at the indicated times by plating serial dilutions of cultures on 7H10 agar. Results shown are the average values ± standard deviations of three independent experiments. Asterisks indicate statistically significant differences compared to the results for the WT, as follows: *, P < 0.05. (A and C) Ciprofloxacin (CIP) at 8 μg/ml and ethambutol (EMB) at 4 μg/ml. (B and D) Rifampin (RIF) at 0.1 μg/ml and EMB at 4 μg/ml.

  • FIG 4 
    • Open in new tab
    • Download powerpoint
    FIG 4 

    Deletion of regX3 suppresses the persister defect of the ΔphoY1 ΔphoY2 mutant. The indicated M. tuberculosis strains were grown in 7H9 medium to mid-exponential phase (OD600 0.5) and diluted to an OD600 of 0.2 prior to adding antibiotics. Cultures were incubated at 37°C with shaking, and viable CFU/ml were enumerated at the indicated times by plating serially diluted cultures on 7H10 agar. Results shown are the average values ± standard deviations of three or five independent experiments. (A) Ciprofloxacin (CIP) at 8 μg/ml and ethambutol (EMB) at 4 μg/ml. (B) Rifampin (RIF) at 0.1 μg/ml and EMB at 4 μg/ml. (C) CIP at 8 μg/ml and isoniazid (INH) at 0.1 μg/ml.

  • FIG 5 
    • Open in new tab
    • Download powerpoint
    FIG 5 

    Loss of pstA1 decreases persister frequency in M. tuberculosis. M. tuberculosis strains were grown to mid-exponential phase (OD600 0.5), diluted in fresh 7H9 medium to an OD600 of 0.2, and then treated with antibiotics. Cultures were incubated with aeration at 37°C, and viable CFU/ml were enumerated at the indicated times by plating serial dilutions on 7H10 agar. Results presented are the average values ± standard errors of three independent experiments. Asterisks indicate statistically significant differences from the results for the WT, as follows: *, P < 0.05; **, P < 0.005. (A) Ciprofloxacin (CIP) at 8 μg/ml and ethambutol (EMB) at 4 μg/ml. (B) CIP at 8 μg/ml and isoniazid (INH) at 0.1 μg/ml. (C) Rifampin (RIF) at 0.1 μg/ml and at EMB 4 μg/ml.

  • FIG 6 
    • Open in new tab
    • Download powerpoint
    FIG 6 

    PstA1 is required for M. tuberculosis persister formation during phosphate-limiting growth. M. tuberculosis strains were grown to mid-exponential phase (OD600 0.5) in complete 7H9 medium, washed twice in Pi-limiting 7H9 containing 2.5 μM Pi, and then diluted to an OD600 of 0.1 in Pi-limiting 7H9 containing 2.5 μM Pi. Cultures were incubated with aeration at 37°C in Pi-limiting 7H9 for 72 h prior to the addition of antibiotics. Viable CFU/ml were enumerated at the indicated times by plating serial dilutions on 7H10 agar. Results presented are the average values ± standard errors of three independent experiments. Asterisks indicate statistically significant differences from the results for the WT, as follows: *, P < 0.05; **, P < 0.005. (A and B) Ciprofloxacin (CIP) at 8 μg/ml and ethambutol (EMB) at 4 μg/ml. (C and D) CIP at 8 μg/ml and isoniazid (INH) at 0.1 μg/ml.

  • FIG 7 
    • Open in new tab
    • Download powerpoint
    FIG 7 

    Persistence of ΔphoY1 ΔphoY2 and ΔpstA1 mutants in mice treated with rifampin or isoniazid. C57BL/6 mice were aerosol infected with ~80 CFU of WT Erdman (A and D) and ΔpstA1 (C and F) strains or ~40 CFU of the ΔphoY1 ΔphoY2 mutant (B and E). Four weeks postinfection, mice were divided into no-drug control (closed squares), rifampin treatment (RIF; open squares), and isoniazid treatment (INH; open triangles) groups. At the indicated time points, groups of mice (n = 4) were sacrificed, and CFU were enumerated by plating serially diluted lung (A to C) and spleen (D to F) homogenates on 7H10 agar. Results presented are the mean values ± standard errors of the means. Asterisks indicate statistically significant differences compared to the results for the no-drug control, as follows: *, P < 0.05; **, P < 0.005. For the ΔpstA1 mutant, the results for both the rifampin and isoniazid treatment groups were significantly different from the results for the no-drug control group in the lungs at week 6 (P < 0.05).

Tables

  • Figures
  • Supplemental Material
  • TABLE 1 

    MICs of antibiotics against M. tuberculosis wild-type and phosphate regulation mutants

    GenotypeMIC90 (μg/ml) ofa:
    CIPEMBINHRIF
    WT0.20.5–10.050.050
    ΔphoY10.210.0250.050
    ΔphoY20.20.50.0250.050
    ΔphoY1 ΔphoY20.1–0.20.50.0250.0125
    ΔphoY1 ΔphoY2/pMVphoY10.20.50.0250.050
    ΔphoY1 ΔphoY2/pMVphoY20.20.50.0250.050
    ΔphoY1 ΔphoY2 ΔregX30.210.0250.025
    ΔphoY1 ΔphoY2 ΔregX3/pNDregX30.210.0250.0125
    ΔpstA10.1–0.20.50.025–0.050.00625
    ΔregX30.20.5–10.025–0.050.025–0.05
    ΔpstA1 ΔregX30.20.5–10.025–0.050.025–0.05
    ΔpstA1/pMVpstA1———0.025–0.05
    ΔpstA1 ΔregX3/pNDregX3———0.00625
    • ↵ a MIC90 (μg/ml) is the minimum concentration required to inhibit 90% of growth compared to the results for the no-drug control. Results are from at least three independent experiments. Ranges are given for strains that exhibited variable MIC90s in two of four experiments. CIP, ciprofloxacin; EMB, ethambutol; INH, isoniazid; RIF, rifampin; —, MIC90 not determined.

  • TABLE 2 

    Polyphosphate quantification in M. tuberculosis wild-type and Pst/SenX3-RegX3 mutant strainsa

    Strainnmol polyP/mg total
    protein (mean ± SD)b
    P value
    (versus WT)
    WT0.09 ± 0.02
    ΔphoY10.13 ± 0.060.258
    ΔphoY20.41 ± 0.170.010
    ΔphoY2/pMVphoY20.19 ± 0.060.023
    ΔphoY1 ΔphoY20.86 ± 0.210.0003
    ΔphoY1 ΔphoY2/pMVphoY10.08 ± 0.020.413
    ΔphoY1 ΔphoY2/pMVphoY20.07 ± 0.020.205
    ΔphoY1 ΔphoY2 ΔregX30.64 ± 0.180.001
    ΔphoY1 ΔphoY2 ΔregX3/pNDregX30.44 ± 0.100.0003
    ΔpstA10.56 ± 0.150.001
    ΔpstA1/pMVpstA10.21 ± 0.100.051
    ΔregX30.07 ± 0.020.306
    ΔpstA1 ΔregX30.09 ± 0.050.957
    ΔpstA1 ΔregX3/pNDregX30.45 ± 0.220.016
    • ↵ a Strains were grown in 20 ml of 7H9 broth until mid-exponential growth phase (OD600 of 0.5) and pelleted by centrifugation prior to polyphosphate extraction.

    • ↵ b Results are mean values ± standard deviations of at least four independent experiments.

Supplemental Material

  • Figures
  • Tables
  • FIG S1 

    Confirmation of phoY1 and phoY2 chromosomal deletions by Southern blotting. (A and B) Genomic DNA from M. tuberculosis Erdman (WT) and ΔphoY1, ΔphoY2, and ΔphoY1 ΔphoY2 mutants was digested with the indicated restriction enzymes, and bands that hybridized to a gene-specific probe were detected by chemiluminescence. Positions of molecular size markers are indicated. (A) PstI digest and phoY1 probe that hybridized to a 1.8-kbp fragment from the WT and a 1.1-kbp fragment from the ΔphoY1 mutants. (B) XhoI digest and phoY2 probe that hybridized to a 2.9-kbp fragment from the WT and a 2.3-kbp fragment from the ΔphoY2 mutants. (C and D) Maps of the phoY1 (C) and phoY2 (D) loci. Genes are indicted by gray arrows. Probes are indicated by red bars. Download FIG S1, EPS file, 0.7 MB.

    Copyright © 2017 Namugenyi et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

  • TABLE S1 

    Doubling times of phoY deletion mutants in Pi-rich 7H9 medium. Download TABLE S1, PDF file, 0.1 MB.

    Copyright © 2017 Namugenyi et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

  • FIG S2 

    The ΔphoY1 ΔphoY2 mutant is hypersensitive to cell wall and reactive oxygen stress. The indicated M. tuberculosis strains were grown to mid-exponential phase (OD600 0.5) in 7H9 medium, diluted to an OD600 of 0.05 in fresh 7H9 medium, and subjected to either sodium dodecyl sulfate (SDS; 0.125%) or hydrogen peroxide (H2O2; 3 mM) treatment for 24 h at 37°C with shaking. At 0 and 24 h, cultures were serially diluted and plated on 7H10 agar for CFU enumeration. Percent survival was calculated as follows: (CFU poststress)/(CFU prestress) × 100. Results presented are the mean values ± standard errors from three independent experiments. Asterisks indicate statistically significant differences in survival compared to the results for the WT, as follows: **, P < 0.005; ***, P < 0.0005. Download FIG S2, EPS file, 0.1 MB.

    Copyright © 2017 Namugenyi et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

  • FIG S3 

    Deletion of phoY1 and phoY2 decreases stationary-phase persister frequency. The indicated M. tuberculosis strains were diluted to an OD600 of 0.05 and grown for 10 days in 7H9 medium to stationary phase before adding 8 μg/ml rifampin. Cultures were incubated at 37°C without shaking. CFU were enumerated at 0, 3, and 9 days by plating serially diluted cultures on 7H10 agar. Percent survival was calculated as follows: (CFU poststress)/(CFU prestress) × 100. Results presented are the mean values ± standard errors from three independent experiments. Asterisks indicate statistically significant differences in survival compared to the results for the WT control, as follows: *, P < 0.05. Download FIG S3, EPS file, 0.1 MB.

    Copyright © 2017 Namugenyi et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

  • FIG S4 

    Increased envelope permeability of the ΔphoY1 ΔphoY2 mutant is caused by deletion of phoY2. M. tuberculosis mc27000, the ΔphoY1 ΔphoY2 mutant, and complemented strains were incubated with 2 μg/ml ethidium bromide and uptake rates were determined by measuring emission at 590 nm upon excitation at 544 nm. Data are expressed as relative fluorescence units (RFU) normalized to the fluorescence at 0 min and are the mean values ± standard errors of at least three independent experiments. Download FIG S4, EPS file, 0.1 MB.

    Copyright © 2017 Namugenyi et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

  • FIG S5 

    Loss of regX3 decreases M. tuberculosis persister frequency when exposed to rifampin and ethambutol. M. tuberculosis strains were grown to mid-exponential phase (OD600 0.5) and diluted in fresh 7H9 medium to an OD600 of 0.2 prior to the addition of antibiotics. Cultures were incubated with aeration at 37°C, and viable CFU/ml were enumerated at the indicated times by plating serial dilutions on 7H10 agar. Results presented are the average values ± standard errors of three independent experiments. Asterisks indicate statistically significant differences from the results for the WT, as follows: *, P < 0.05; **, P < 0.005. (A) Ciprofloxacin (CIP) at 8 μg/ml and ethambutol (EMB) at 4 μg/ml. (B) CIP at 8 μg/ml and isoniazid (INH) at 0.1 μg/ml. (C) Rifampin (RIF) at 0.1 μg/ml and EMB at 4 μg/ml. Download FIG S5, EPS file, 0.1 MB.

    Copyright © 2017 Namugenyi et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

  • FIG S6 

    The ΔphoY1 ΔphoY2 mutant is attenuated in vivo. C57BL/6 mice were aerosol infected with ~80 CFU of the WT Erdman or ΔpstA1 strains or ~40 CFU of the ΔphoY1 ΔphoY2 mutant. At the indicated time points, groups of mice (n = 4) were sacrificed and CFU were enumerated by plating serially diluted lung (A) and spleen (B) homogenates on 7H10 agar. Results shown are the mean values ± standard errors of the means. Asterisks indicate statistically significant differences between the results for the WT and ΔphoY1 ΔphoY2 or ΔpstA1 mutants, as follows: *, P < 0.05; **, P < 0.005. Download FIG S6, EPS file, 0.1 MB.

    Copyright © 2017 Namugenyi et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

  • TABLE S2 

    Percent survival of bacteria in lungs and spleens of antibiotic-treated mice relative to survival in no-drug control mice. Download TABLE S2, PDF file, 0.1 MB.

    Copyright © 2017 Namugenyi et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

  • FIG S7 

    ppk1 is overexpressed in the ΔphoY1 ΔphoY2 mutant. RNA was isolated from the indicated M. tuberculosis strains grown to mid-exponential phase (OD600 0.5) in 7H9 medium. Expression of ppk1, ppk2, ppx1, and ppx2 transcripts was measured using quantitative reverse transcription-PCR and normalized to the sigA transcript level. Data shown are the mean values ± standard deviations of three independent experiments. Asterisks indicate statistically significant differences in transcript abundance compared to the results for the WT, as follows: *, P < 0.05. Download FIG S7, EPS file, 0.2 MB.

    Copyright © 2017 Namugenyi et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

  • TABLE S3 

    Oligonucleotide primers used for cloning, strain construction, or real-time quantitative RT-PCR (qRT-PCR). Download TABLE S3, PDF file, 0.1 MB.

    Copyright © 2017 Namugenyi et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

PreviousNext
Back to top
Download PDF
Citation Tools
Mycobacterium tuberculosis PhoY Proteins Promote Persister Formation by Mediating Pst/SenX3-RegX3 Phosphate Sensing
Sarah B. Namugenyi, Alisha M. Aagesen, Sarah R. Elliott, Anna D. Tischler
mBio Jul 2017, 8 (4) e00494-17; DOI: 10.1128/mBio.00494-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mBio article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mycobacterium tuberculosis PhoY Proteins Promote Persister Formation by Mediating Pst/SenX3-RegX3 Phosphate Sensing
(Your Name) has forwarded a page to you from mBio
(Your Name) thought you would be interested in this article in mBio.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mycobacterium tuberculosis PhoY Proteins Promote Persister Formation by Mediating Pst/SenX3-RegX3 Phosphate Sensing
Sarah B. Namugenyi, Alisha M. Aagesen, Sarah R. Elliott, Anna D. Tischler
mBio Jul 2017, 8 (4) e00494-17; DOI: 10.1128/mBio.00494-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

ATP-Binding Cassette Transporters
Bacterial Proteins
Mycobacterium tuberculosis
Phosphates
Phosphotransferases
Mycobacterium tuberculosis
PhoU
Pst system
RegX3
antibiotic tolerance
persister
phosphate
rifampin

Related Articles

Cited By...

About

  • About mBio
  • Editor in Chief
  • Board of Editors
  • AAM Fellows
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Article Types
  • Ethics
  • Contact Us

Follow #mBio

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2150-7511